Cascade of Inflammatory, Fibrotic Processes, and Stress-Induced Senescence in Chronic GVHD-Related Dry Eye Disease
- PMID: 34204098
- PMCID: PMC8201206
- DOI: 10.3390/ijms22116114
Cascade of Inflammatory, Fibrotic Processes, and Stress-Induced Senescence in Chronic GVHD-Related Dry Eye Disease
Abstract
Ocular graft-versus-host disease (GVHD) is a major complication after allogeneic hematopoietic stem cell transplantation. Ocular GVHD affects recipients' visual function and quality of life. Recent advanced research in this area has gradually attracted attention from a wide range of physicians and ophthalmologists. This review highlights the mechanism of immune processes and the molecular mechanism, including several inflammation cascades, pathogenic fibrosis, and stress-induced senescence related to ocular GVHD, in basic spectrum topics in this area. How the disease develops and what kinds of cells participate in ocular GVHD are discussed. Although the classical immune process is a main pathological pathway in this disease, senescence-associated changes in immune cells and stem cells may also drive this disease. The DNA damage response, p16/p21, and the expression of markers associated with the senescence-associated secretory phenotype (SASP) are seen in ocular tissue in GVHD. Macrophages, T cells, and mesenchymal cells from donors or recipients that increasingly infiltrate the ocular surface serve as the source of increased secretion of IL-6, which is a major SASP driver. Agents capable of reversing the changes, including senolytic reagents or those that can suppress the SASP seen in GVHD, provide new potential targets for the treatment of GVHD. Creating innovative therapies for ocular GVHD is necessary to treat this intractable ocular disease.
Keywords: dry eye disease; graft-versus-host disease; molecular mechanism; stress-induced senescence.
Conflict of interest statement
The authors have a patent and is applying the patents as described above.
Figures


Similar articles
-
Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation.Cornea. 2003 Oct;22(7 Suppl):S19-27. doi: 10.1097/00003226-200310001-00004. Cornea. 2003. PMID: 14703704 Review.
-
Senescence-associated secretory phenotype promotes chronic ocular graft-vs-host disease in mice and humans.FASEB J. 2020 Aug;34(8):10778-10800. doi: 10.1096/fj.201900218R. Epub 2020 Jul 3. FASEB J. 2020. PMID: 32619061
-
A Review of Ocular Graft-Versus-Host Disease.Optom Vis Sci. 2017 May;94(5):545-555. doi: 10.1097/OPX.0000000000001071. Optom Vis Sci. 2017. PMID: 28422804 Review.
-
Analyses and Correlation of Pathologic and Ocular Cutaneous Changes in Murine Graft versus Host Disease.Int J Mol Sci. 2021 Dec 24;23(1):184. doi: 10.3390/ijms23010184. Int J Mol Sci. 2021. PMID: 35008621 Free PMC article.
-
Commensal microflora in human conjunctiva; characteristics of microflora in the patients with chronic ocular graft-versus-host disease.Ocul Surf. 2019 Apr;17(2):265-271. doi: 10.1016/j.jtos.2019.02.001. Epub 2019 Feb 10. Ocul Surf. 2019. PMID: 30742990
Cited by
-
Recent advances in ocular graft-versus-host disease.Front Immunol. 2023 Jan 25;14:1092108. doi: 10.3389/fimmu.2023.1092108. eCollection 2023. Front Immunol. 2023. PMID: 36761771 Free PMC article. Review.
-
Therapeutic Potential of a Senolytic Approach in a Murine Model of Chronic GVHD.Biology (Basel). 2023 Apr 25;12(5):647. doi: 10.3390/biology12050647. Biology (Basel). 2023. PMID: 37237461 Free PMC article.
-
[Chinese expert consensus on ocular chronic graft-versus-host disease (2023)].Zhonghua Xue Ye Xue Za Zhi. 2023 Jun 14;44(6):449-457. doi: 10.3760/cma.j.issn.0253-2727.2023.06.002. Zhonghua Xue Ye Xue Za Zhi. 2023. PMID: 37550199 Free PMC article. Chinese. No abstract available.
-
Long-term clinical outcomes and predictive factors in patients with chronic ocular graft-versus-host disease.Sci Rep. 2022 Jul 29;12(1):12985. doi: 10.1038/s41598-022-17032-2. Sci Rep. 2022. PMID: 35906359 Free PMC article.
-
Infectious and Noninfectious Corneal Ulcers in Ocular Graft-Versus-Host Disease: Epidemiology, Clinical Characteristics, and Outcomes.Am J Ophthalmol. 2024 Jan;257:236-246. doi: 10.1016/j.ajo.2023.09.018. Epub 2023 Sep 28. Am J Ophthalmol. 2024. PMID: 37774993 Free PMC article.
References
-
- Jagasia M.H. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biol. Blood Marrow Transplant. J. Am. Soc. Blood Marrow Transplant. 2015;21:389–401.e1. doi: 10.1016/j.bbmt.2014.12.001. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical